BFM
CPRX

Boothbay Fund Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Boothbay Fund Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
+9,701
New +$286K ﹤0.01% 1728
2026
Q1 		– Sell
-8,733
Closed -$204K – 2133
2025
Q4 		$204K Sell
8,733
-11,683
-57% -$260K ﹤0.01% 1654
2025
Q3 		$402K Sell
20,416
-20,175
-50% -$415K 0.01% 1290
2025
Q2 		$881K Sell
40,591
-14,292
-26% -$337K 0.02% 725
2025
Q1 		$1.33M Sell
54,883
-21,982
-29% -$495K 0.04% 537
2024
Q4 		$1.6M Sell
76,865
-29,362
-28% -$631K 0.04% 497
2024
Q3 		$2.11M Sell
106,227
-14,623
-12% -$271K 0.05% 499
2024
Q2 		$1.87M Hold
120,850
– – 0.04% 521
2024
Q1 		$1.93M Buy
120,850
+12,524
+12% +$189K 0.04% 522
2023
Q4 		$1.82M Hold
108,326
– – 0.05% 527
2023
Q3 		$1.27M Buy
+108,326
New +$1.45M 0.03% 662
2018
Q4 		– Sell
-100,181
Closed -$379K – 697
2018
Q3 		$379K Buy
100,181
+16,000
+19% +$50.1K 0.04% 446
2018
Q2 		$263K Sell
84,181
-38,819
-32% -$118K 0.02% 522
2018
Q1 		$294K Buy
+123,000
New +$409K 0.03% 476
2017
Q3 		– Sell
-68,970
Closed -$190K – 622
2017
Q2 		$190K Sell
68,970
-66,902
-49% -$140K 0.04% 572
2017
Q1 		$265K Buy
+135,872
New +$173K 0.05% 476
2016
Q1 		– Sell
-39,695
Closed -$97K – 622
2015
Q4 		$97K Sell
39,695
-23,972
-38% -$68.7K 0.04% 507
2015
Q3 		$191K Buy
+63,667
New +$275K 0.09% 333

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boothbay Fund Management's CPRX Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 9,701 shares worth $305K. The stake represents ﹤0.01% of the portfolio and ranks #1728 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in CPRX as recently as Q4 2025.

Boothbay Fund Management first reported a position in CPRX in Q3 2015 and has held it in 18 quarters since. The position peaked at $2.11M in Q3 2024. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Boothbay Fund Management held 9,701 shares of Catalyst Pharmaceutical worth $305K as of Q2 2026.
  • Catalyst Pharmaceutical was a new Boothbay Fund Management position in Q2 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1728 holding.
  • Boothbay Fund Management first reported a position in Catalyst Pharmaceutical in Q3 2015 and has held it in 18 quarters since.
  • Boothbay Fund Management's Catalyst Pharmaceutical position peaked at $2.11M in Q3 2024.
  • 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.